• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种双模态列线图作为辅助工具,用于减少超声和乳腺 X 线摄影 BI-RADS 评估不一致时不必要的乳腺活检。

A bimodal nomogram as an adjunct tool to reduce unnecessary breast biopsy following discordant ultrasonic and mammographic BI-RADS assessment.

机构信息

Department of Ultrasound, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.

Department of Imaging, Zengcheng Branch of Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.

出版信息

Eur Radiol. 2024 Apr;34(4):2608-2618. doi: 10.1007/s00330-023-10255-5. Epub 2023 Oct 16.

DOI:10.1007/s00330-023-10255-5
PMID:37840099
Abstract

OBJECTIVE

To develop a bimodal nomogram to reduce unnecessary biopsies in breast lesions with discordant ultrasound (US) and mammography (MG) Breast Imaging Reporting and Data System (BI-RADS) assessments.

METHODS

This retrospective study enrolled 706 women following opportunistic screening or diagnosis with discordant US and MG BI-RADS assessments (where one assessed a lesion as BI-RADS 4 or 5, while the other assessed the same lesion as BI-RADS 0, 2, or 3) from two medical centres between June 2019 and June 2021. Univariable and multivariable logistic regression analyses were used to develop the nomogram. DeLong's and McNemar's tests were used to assess the model's performance.

RESULTS

Age, MG features (margin, shape, and density in masses, suspicious calcifications, and architectural distortion), and US features (margin and shape in masses as well as calcifications) were independent risk factors for breast cancer. The nomogram obtained an area under the curve of 0.87 (95% confidence interval (CI), 0.83-0.91), 0.91 (95% CI, 0.87 - 0.96), and 0.92 (95% CI, 0.86-0.98) in the training, internal validation, and external testing samples, respectively, and demonstrated consistency in calibration curves. Coupling the nomogram with US reduced unnecessary biopsies from 74 to 44% and the missed malignancies rate from 13 to 2%. Similarly, coupling with MG reduced missed malignancies from 20 to 6%, and 63% of patients avoided unnecessary biopsies. Interobserver agreement between US and MG increased from - 0.708 (poor agreement) to 0.700 (substantial agreement) with the nomogram.

CONCLUSION

When US and MG BI-RADS assessments are discordant, incorporating the nomogram may improve the diagnostic accuracy, avoid unnecessary breast biopsies, and minimise missed diagnoses.

CLINICAL RELEVANCE STATEMENT

The nomogram developed in this study could be used as a computer program to assist radiologists with detecting breast cancer and ensuring more precise management and improved treatment decisions for breast lesions with discordant assessments in clinical practice.

KEY POINTS

• Coupling the nomogram with US and mammography improves the detection of breast cancers without the risk of unnecessary biopsy or missed malignancies. • The nomogram increases mammography and US interobserver agreement and enhances the consistency of decision-making. • The nomogram has the potential to be a computer program to assist radiologists in identifying breast cancer and making optimal decisions.

摘要

目的

建立一种双模态列线图,以减少超声(US)和乳腺摄影(MG)乳腺成像报告和数据系统(BI-RADS)评估不一致的乳腺病变中不必要的活检。

方法

本回顾性研究纳入了 2019 年 6 月至 2021 年 6 月期间,在两个医疗中心进行机会性筛查或诊断的 706 名 US 和 MG BI-RADS 评估不一致的女性(其中一个评估病变为 BI-RADS 4 或 5,而另一个评估相同病变为 BI-RADS 0、2 或 3)。使用单变量和多变量逻辑回归分析来开发列线图。使用 DeLong 检验和 McNemar 检验评估模型性能。

结果

年龄、MG 特征(肿块的边缘、形状和密度、可疑钙化和结构扭曲)和 US 特征(肿块的边缘和形状以及钙化)是乳腺癌的独立危险因素。该列线图在训练、内部验证和外部测试样本中的曲线下面积分别为 0.87(95%置信区间(CI):0.83-0.91)、0.91(95%CI:0.87-0.96)和 0.92(95%CI:0.86-0.98),校准曲线具有一致性。将列线图与 US 相结合,将不必要的活检率从 74%降至 44%,将漏诊恶性肿瘤率从 13%降至 2%。同样,将列线图与 MG 相结合,将漏诊的恶性肿瘤率从 20%降至 6%,并使 63%的患者避免了不必要的活检。MG 和 US 的观察者间一致性从-0.708(差)增加到 0.700(中)。

结论

当 US 和 MG BI-RADS 评估不一致时,加入列线图可能会提高诊断准确性,避免不必要的乳腺活检,并最大限度地减少漏诊。

临床相关性声明

本研究中开发的列线图可作为计算机程序,用于协助放射科医生检测乳腺癌,并确保在临床实践中对评估不一致的乳腺病变进行更精确的管理和改善治疗决策。

关键点

  1. 将列线图与 US 和 mammography 相结合,可以提高乳腺癌的检出率,同时避免不必要的活检或漏诊恶性肿瘤的风险。

  2. 列线图增加了 mammography 和 US 观察者间的一致性,并增强了决策的一致性。

  3. 列线图有可能成为一种计算机程序,帮助放射科医生识别乳腺癌并做出最佳决策。

相似文献

1
A bimodal nomogram as an adjunct tool to reduce unnecessary breast biopsy following discordant ultrasonic and mammographic BI-RADS assessment.一种双模态列线图作为辅助工具,用于减少超声和乳腺 X 线摄影 BI-RADS 评估不一致时不必要的乳腺活检。
Eur Radiol. 2024 Apr;34(4):2608-2618. doi: 10.1007/s00330-023-10255-5. Epub 2023 Oct 16.
2
Utility of Second-look Ultrasonography in Distinguishing BI-RADS 4 Calcifications Detected on Mammography: An observational study.乳腺 X 线摄影检出 BI-RADS 4 类钙化的二探超声检查的效用:一项观察性研究。
Medicine (Baltimore). 2024 Jul 12;103(28):e38841. doi: 10.1097/MD.0000000000038841.
3
Breast cancer risk prediction model: a nomogram based on common mammographic screening findings.乳腺癌风险预测模型:基于常见乳腺筛查结果的列线图。
Eur Radiol. 2013 Sep;23(9):2413-9. doi: 10.1007/s00330-013-2836-8. Epub 2013 Apr 18.
4
Predicting Breast Cancer in Breast Imaging Reporting and Data System (BI-RADS) Ultrasound Category 4 or 5 Lesions: A Nomogram Combining Radiomics and BI-RADS.基于影像报告和数据系统(BI-RADS)超声分类 4 或 5 级病变的乳腺影像中预测乳腺癌:结合影像组学和 BI-RADS 的列线图
Sci Rep. 2019 Aug 15;9(1):11921. doi: 10.1038/s41598-019-48488-4.
5
Biopsy or Follow-up: AI Improves the Clinical Strategy of US BI-RADS 4A Breast Nodules Using a Convolutional Neural Network.活检还是随访:使用卷积神经网络,人工智能改善了 US BI-RADS 4A 乳腺结节的临床策略。
Clin Breast Cancer. 2024 Jul;24(5):e319-e332.e2. doi: 10.1016/j.clbc.2024.02.003. Epub 2024 Feb 20.
6
An Improved Nomogram to Reduce False-Positive Biopsy Rates of Breast Imaging Reporting and Data System Ultrasonography Category 4A Lesions.一种改进的列线图,以降低乳腺影像报告和数据系统超声4A类病变活检假阳性率。
Cancer Control. 2022 Jan-Dec;29:10732748221122703. doi: 10.1177/10732748221122703.
7
Can Ultrasound Elastography Help Better Manage Mammographic BI-RADS Category 4 Breast Lesions?超声弹性成像能否帮助更好地管理乳腺 BI-RADS 4 类病变?
Clin Breast Cancer. 2022 Jun;22(4):e407-e416. doi: 10.1016/j.clbc.2021.10.009. Epub 2021 Oct 25.
8
A nomogram to predict for malignant diagnosis of BI-RADS Category 4 breast lesions.用于预测 BI-RADS 类别 4 乳腺病变恶性诊断的列线图。
J Surg Oncol. 2010 Sep 1;102(3):220-4. doi: 10.1002/jso.21616.
9
Value of contrast-enhanced mammography combined with the Kaiser score for clinical decision-making regarding tomosynthesis BI-RADS 4A lesions.对比增强乳腺摄影联合 Kaiser 评分对断层合成 BI-RADS 4A 病变临床决策的价值。
Eur Radiol. 2022 Nov;32(11):7439-7447. doi: 10.1007/s00330-022-08810-7. Epub 2022 May 31.
10
Inter-reader Variability in the Use of BI-RADS Descriptors for Suspicious Findings on Diagnostic Mammography: A Multi-institution Study of 10 Academic Radiologists.乳腺影像报告和数据系统(BI-RADS)描述符在诊断性乳腺钼靶检查中对可疑发现的使用的阅片者间差异:一项针对10名学术放射科医生的多机构研究
Acad Radiol. 2017 Jan;24(1):60-66. doi: 10.1016/j.acra.2016.09.010. Epub 2016 Oct 25.

引用本文的文献

1
Optimizing breast lesions diagnosis and decision-making with a deep learning fusion model integrating ultrasound and mammography: a dual-center retrospective study.使用整合超声和乳腺X线摄影的深度学习融合模型优化乳腺病变诊断与决策:一项双中心回顾性研究
Breast Cancer Res. 2025 May 14;27(1):80. doi: 10.1186/s13058-025-02033-6.
2
Obesity-Associated Breast Cancer: Analysis of Risk Factors and Current Clinical Evaluation.肥胖相关性乳腺癌:危险因素分析与临床评估现状。
Adv Exp Med Biol. 2024;1460:767-819. doi: 10.1007/978-3-031-63657-8_26.

本文引用的文献

1
Nomogram as a novel predictive tool for lymph node metastasis in T1 colorectal cancer treated with endoscopic resection: a nationwide, multicenter study.列线图作为内镜切除治疗 T1 结直肠癌淋巴结转移的新型预测工具:一项全国多中心研究。
Gastrointest Endosc. 2023 Jun;97(6):1119-1128.e5. doi: 10.1016/j.gie.2023.01.022. Epub 2023 Jan 18.
2
Multilevel Factors Associated With Time to Biopsy After Abnormal Screening Mammography Results by Race and Ethnicity.按种族和民族划分,异常筛查性乳房 X 光检查结果后活检时间的多层次相关因素。
JAMA Oncol. 2022 Aug 1;8(8):1115-1126. doi: 10.1001/jamaoncol.2022.1990.
3
Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI).
欧洲乳腺影像学会(EUSOBI)关于致密型乳腺女性乳腺癌筛查的建议。
Eur Radiol. 2022 Jun;32(6):4036-4045. doi: 10.1007/s00330-022-08617-6. Epub 2022 Mar 8.
4
Downgrade BI-RADS 4A Patients Using Nomogram Based on Breast Magnetic Resonance Imaging, Ultrasound, and Mammography.基于乳腺磁共振成像、超声和乳腺X线摄影的列线图对BI-RADS 4A级患者进行降级评估。
Front Oncol. 2022 Jan 27;12:807402. doi: 10.3389/fonc.2022.807402. eCollection 2022.
5
Comparative Study of Digital Breast Tomosynthesis (DBT) with and without Ultrasound versus Breast Magnetic Resonance Imaging (MRI) in Detecting Breast Lesion.数字乳腺断层合成术(DBT)联合与不联合超声与乳腺磁共振成像(MRI)在乳腺病变检测中的对比研究。
Int J Environ Res Public Health. 2022 Jan 11;19(2):759. doi: 10.3390/ijerph19020759.
6
Artificial intelligence system reduces false-positive findings in the interpretation of breast ultrasound exams.人工智能系统减少了乳腺超声检查中假阳性结果的出现。
Nat Commun. 2021 Sep 24;12(1):5645. doi: 10.1038/s41467-021-26023-2.
7
Prospective assessment of breast cancer risk from multimodal multiview ultrasound images via clinically applicable deep learning.通过临床适用的深度学习对多模态多角度超声图像进行前瞻性乳腺癌风险评估。
Nat Biomed Eng. 2021 Jun;5(6):522-532. doi: 10.1038/s41551-021-00711-2. Epub 2021 Apr 19.
8
Artificial intelligence for breast ultrasound: An adjunct tool to reduce excessive lesion biopsy.人工智能在乳腺超声中的应用:减少过度病变活检的辅助工具。
Eur J Radiol. 2021 May;138:109624. doi: 10.1016/j.ejrad.2021.109624. Epub 2021 Mar 4.
9
Breast cancer, screening and diagnostic tools: All you need to know.乳腺癌、筛查和诊断工具:你需要知道的一切。
Crit Rev Oncol Hematol. 2021 Jan;157:103174. doi: 10.1016/j.critrevonc.2020.103174. Epub 2020 Nov 11.
10
Mammography features for early markers of aggressive breast cancer subtypes and tumor characteristics: A population-based cohort study.乳腺摄影表现与侵袭性乳腺癌亚型和肿瘤特征的早期标志物:基于人群的队列研究。
Int J Cancer. 2021 Mar 15;148(6):1351-1359. doi: 10.1002/ijc.33309. Epub 2020 Oct 6.